title: Unilateral uveitis with vitreous haze following zoledronic Acid therapy for osteoporosis.
abstract: Zoledronic acid is widely used in the treatment of osteoporosis and other bone diseases. However, patients may experience adverse effects involving the anterior segment of the eye following intravenous infusion. This paper reports a rare case of uveitis involving the vitreous cavity following the intravenous administration of zoledronic acid.
authors.affiliation: Centro Brasileiro da Visão , Brasília , Brazil and.
authors.forename: Clovis Arcoverde
authors.initials: CA
authors.lastname: Freitas-Neto
authors.forename: Willian Breno
authors.initials: WB
authors.lastname: de Oliveira Fagundes
authors.forename: Manoel
authors.initials: M
authors.lastname: Ribeiro
authors.forename: Katia Delalíbera
authors.initials: KD
authors.lastname: Pacheco
authors.forename: Luiz Guilherme
authors.initials: LG
authors.lastname: Freitas
authors.forename: Marcos Pereira
authors.initials: MP
authors.lastname: Ávila
mesh_terms: D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007262:Infusions, Intravenous; D007429:Intraocular Pressure; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D041623:Tomography, Optical Coherence; D014463:Ultrasonography; D014605:Uveitis / Q000139:chemically induced* / Q000175:diagnosis; D014792:Visual Acuity; D014822:Vitreous Body / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid
keywords: Anterior chamber; drug toxicity; osteoporosis; uveitis; vitreous body